Brenda S. Furlow - Aug 31, 2021 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
SVP - General Counsel
Signature
/s/ Sarah Tucher as Attorney-in-Fact for Brenda S. Furlow pursuant to Power of Attorney previously filed.
Stock symbol
TECH
Transactions as of
Aug 31, 2021
Transactions value $
-$1,903,061
Form type
4
Date filed
9/2/2021, 04:48 PM
Previous filing
Aug 23, 2021
Next filing
Sep 7, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Options Exercise $625K +5K +65.62% $125.05 12.6K Aug 31, 2021 Direct
transaction TECH Common Stock Sale -$163K -323 -2.56% $503.24* 12.3K Aug 31, 2021 Direct F1
transaction TECH Common Stock Sale -$793K -1.57K -12.76% $505.26* 10.7K Aug 31, 2021 Direct F2
transaction TECH Common Stock Sale -$1.57M -3.11K -28.97% $506.12* 7.62K Aug 31, 2021 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Stock Options (Right to Buy) Options Exercise $0 -5K -23.39% $0.00 16.4K Aug 31, 2021 Common Stock 5K $125.05 Direct F5
holding TECH Stock Options (Right to Buy) 921 Aug 31, 2021 Common Stock 921 $108.49 Direct F5
holding TECH Stock Options (Right to Buy) 7.34K Aug 31, 2021 Common Stock 7.34K $177.32 Direct F5
holding TECH Stock Options (Right to Buy) 9.79K Aug 31, 2021 Common Stock 9.79K $177.32 Direct F6
holding TECH Restricted Stock Units 1.97K Aug 31, 2021 Common Stock 1.97K Direct F4, F7
holding TECH Stock Options (Right to Buy) 9.97K Aug 31, 2021 Common Stock 9.97K $190.41 Direct F7
holding TECH Stock Options (Right to Buy) 13.3K Aug 31, 2021 Common Stock 13.3K $190.41 Direct F8
holding TECH Restricted Stock Units 1.68K Aug 31, 2021 Common Stock 1.68K Direct F4, F9
holding TECH Stock Options (Right to Buy) 7.49K Aug 31, 2021 Common Stock 7.49K $267.87 Direct F9
holding TECH Stock Options (Right to Buy) 9.99K Aug 31, 2021 Common Stock 9.99K $267.87 Direct F10
holding TECH Stock Options (Right to Buy) 8.33K Aug 31, 2021 Common Stock 8.33K $267.87 Direct F11
holding TECH Stock Options (Right to Buy) 8.33K Aug 31, 2021 Common Stock 8.33K $267.87 Direct F12
holding TECH Stock Options (Right to Buy) 11K Aug 31, 2021 Common Stock 11K $372.44 Direct
holding TECH Restricted Stock Units 1.17K Aug 31, 2021 Common Stock 1.17K Direct F4, F13
holding TECH Stock Options (Right to Buy) 4.56K Aug 31, 2021 Common Stock 4.56K $481.82 Direct F13
holding TECH Stock Options (Right to Buy) 6.08K Aug 31, 2021 Common Stock 6.08K $481.82 Direct F14
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $503.06 to $503.43, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $504.63 to $505.57, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $505.92 to $506.40, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F5 Fully exercisable.
F6 Options to purchase 2,447 shares vest on each of 8/8/2019 and 8/8/2020 and options to purchase 2,446 shares vest on each of 8/8/2021 and 8/8/2022.
F7 Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F8 Options to purchase 3,323 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 3,322 shares vest on each of 8/7/2022 and 8/7/2023.
F9 Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F10 Options to purchase 2,498 shares vest on each of 8/5/2021 and 8/5/2022 and options to purchase 2,497 shares vest on each of 8/5/2023 and 8/5/2024.
F11 Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
F12 Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.
F13 Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F14 Options to purchase 1,520 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.